Tapewire

Nasdaq · USD

INGN

Inogen Inc

Export transactions ↓
Tapewire entity
2083
SEC CIK
0001294133
Parsed reports
416

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202601
Jun 202600
Jul 202601
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2025 Filed Mar 4, 2025 23:41 UTC
Smith Kevin Raymond MerrillDirector · CEO and President
GrantCommon Stock 53,975 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032638 · ownership.xml · nonDerivative · entry 4

Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 84,662

F3 · shares: The reported securities represent shares earned and vested on March 1, 2025 based on achievement of the financial performance conditions for the 2024 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on November 10, 2023.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:41 UTC
Smith Kevin Raymond MerrillDirector · CEO and President
Tax withholdingCommon Stock 13,700 $8.33 $114,121.00
Disclosure

SEC source: 0000950170-25-032638 · ownership.xml · nonDerivative · entry 3

Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,687

F2 · shares: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2025.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:41 UTC
Smith Kevin Raymond MerrillDirector · CEO and President
Exercise / conversionCommon Stock 28,333 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032638 · ownership.xml · nonDerivative · entry 2

Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,387

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:41 UTC
Smith Kevin Raymond MerrillDirector · CEO and President
GrantCommon Stock 1,500 $8.33 $12,495.00
Disclosure

SEC source: 0000950170-25-032638 · ownership.xml · nonDerivative · entry 1

Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,054

F1 · shares: Shares acquired through the Company's 2014 Employee Stock Purchase Plan.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 18:43 UTC
Smith Kevin P.EVP, Bus Dev, GC & Sec
GrantRestricted Stock Unit · Derivative 42,016 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032643 · ownership.xml · derivative · entry 2

Smith Kevin P. · CIK 0002031211 · EVP, Bus Dev, GC & Sec

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,016

Underlying: Common Stock · 42,016 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:44 UTC
Ramade GregoireChief Commercial Officer
GrantRestricted Stock Unit · Derivative 39,015 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032645 · ownership.xml · derivative · entry 1

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,015

Underlying: Common Stock · 39,015 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:42 UTC
Bourque Michael J.EVP, CFO & Treasurer
GrantRestricted Stock Unit · Derivative 51,020 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032642 · ownership.xml · derivative · entry 7

Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,020

Underlying: Common Stock · 51,020 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F6 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F6 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:41 UTC
Smith Kevin Raymond MerrillDirector · CEO and President
GrantRestricted Stock Unit · Derivative 90,036 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032638 · ownership.xml · derivative · entry 7

Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,036

Underlying: Common Stock · 90,036 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F7 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F7 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 17:11 UTC GrantCommon Stock 9,112 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-013698 · ownership.xml · nonDerivative · entry 1

Sahney Mira Kirti · CIK 0002054249 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,112

F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award. The award will vest on May 14, 2025, which is the same date as other non-employee director awards issued by Inogen that were outstanding as of the grant date, subject to the reporting person continuing to serve as a director through the vesting date.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 22:05 UTC
Ramade GregoireChief Commercial Officer
Exercise / conversionRestricted Stock Unit · Derivative 31,565 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-132856 · ownership.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,131

Underlying: Common Stock · 31,565 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 22:05 UTC
Ramade GregoireChief Commercial Officer
Tax withholdingCommon Stock 12,942 $9.71 $125,666.82
Disclosure

SEC source: 0000950170-24-132856 · ownership.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,623

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2024.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 22:05 UTC
Ramade GregoireChief Commercial Officer
Exercise / conversionCommon Stock 31,565 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-132856 · ownership.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,565

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 22:08 UTC
Smith Kevin Raymond MerrillDirector · CEO and President
Exercise / conversionRestricted Stock Unit · Derivative 28,333 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-132860 · ownership.xml · derivative · entry 3

Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,667

Underlying: Common Stock · 28,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 22:08 UTC
Smith Kevin Raymond MerrillDirector · CEO and President
Tax withholdingCommon Stock 13,779 $9.71 $133,794.09
Disclosure

SEC source: 0000950170-24-132860 · ownership.xml · nonDerivative · entry 2

Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,554

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2024.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 22:08 UTC
Smith Kevin Raymond MerrillDirector · CEO and President
Exercise / conversionCommon Stock 28,333 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-132860 · ownership.xml · nonDerivative · entry 1

Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 22, 2024 Filed Jul 24, 2024 19:45 UTC
Smith Kevin P.EVP, Bus Dev, GC & Sec
GrantRestricted Stock Unit · Derivative 54,406 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-086207 · ownership.xml · derivative · entry 1

Smith Kevin P. · CIK 0002031211 · EVP, Bus Dev, GC & Sec

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,406

Underlying: Common Stock · 54,406 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from September 1, 2024 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from September 1, 2024 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 17:21 UTC GrantCommon Stock 21,871 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-070904 · ownership.xml · nonDerivative · entry 1

Boehnlein Glenn S · CIK 0001670936 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,273

F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:18 UTC GrantCommon Stock 21,871 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-070890 · ownership.xml · nonDerivative · entry 1

West Thomas A. · CIK 0001620705 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,677

F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:44 UTC GrantCommon Stock 21,871 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-070932 · ownership.xml · nonDerivative · entry 1

Rider Heather D. · CIK 0001616363 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,589

F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:23 UTC GrantCommon Stock 21,871 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-070911 · ownership.xml · nonDerivative · entry 1

Mora Elizabeth · CIK 0001548935 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,568

F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:20 UTC
King Kevin MDirector
GrantCommon Stock 21,871 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-070902 · ownership.xml · nonDerivative · entry 1

King Kevin M · CIK 0001385014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,273

F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:16 UTC GrantCommon Stock 21,871 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-070879 · ownership.xml · nonDerivative · entry 1

Ladone Mary Kay · CIK 0001760737 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,273

F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule.

Read SEC document
June 01, 2024 Filed Jun 4, 2024 21:08 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Exercise / conversionRestricted Stock Unit · Derivative 577 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-068828 · ownership.xml · derivative · entry 3

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,882

Underlying: Common Stock · 577 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

Read SEC document
June 01, 2024 Filed Jun 4, 2024 21:08 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Tax withholdingCommon Stock 339 $8.30 $2,813.70
Disclosure

SEC source: 0000950170-24-068828 · ownership.xml · nonDerivative · entry 2

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,690

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2024.

Read SEC document
June 01, 2024 Filed Jun 4, 2024 21:08 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Exercise / conversionCommon Stock 577 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-068828 · ownership.xml · nonDerivative · entry 1

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2024 Filed May 14, 2024 22:43 UTC
Somer JasonEVP, Gen. Counsel & Secretary
SaleCommon Stock 10,000 $8.56 $85,600.00
Disclosure

SEC source: 0000950170-24-059880 · ownership.xml · nonDerivative · entry 1

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,452

F1 · price: Represents the weighted average share price of an aggregate total of 10,000 shares sold in the price range of $8.41 to $8.73 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2024 Filed May 3, 2024 22:15 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Exercise / conversionRestricted Stock Unit · Derivative 19,276 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-053102 · ownership.xml · derivative · entry 3

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,276 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024.

Read SEC document
May 01, 2024 Filed May 3, 2024 22:15 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Tax withholdingCommon Stock 11,312 $7.05 $79,749.60
Disclosure

SEC source: 0000950170-24-053102 · ownership.xml · nonDerivative · entry 2

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,452

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on May 1, 2024.

Read SEC document
May 01, 2024 Filed May 3, 2024 22:15 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Exercise / conversionCommon Stock 19,276 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-053102 · ownership.xml · nonDerivative · entry 1

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2024 Filed May 3, 2024 22:14 UTC
Glezer StanislavEVP, R&D & Chief Med. Officer
Exercise / conversionRestricted Stock Unit · Derivative 32,638 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-053100 · ownership.xml · derivative · entry 3

Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 32,638 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024

F3 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024

Read SEC document
May 01, 2024 Filed May 3, 2024 22:14 UTC
Glezer StanislavEVP, R&D & Chief Med. Officer
Tax withholdingCommon Stock 16,695 $7.05 $117,699.75
Disclosure

SEC source: 0000950170-24-053100 · ownership.xml · nonDerivative · entry 2

Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,049

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on May 1, 2024.

Read SEC document
May 01, 2024 Filed May 3, 2024 22:14 UTC
Glezer StanislavEVP, R&D & Chief Med. Officer
Exercise / conversionCommon Stock 32,638 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-053100 · ownership.xml · nonDerivative · entry 1

Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2024 Filed Mar 7, 2024 01:46 UTC
Bourque Michael J.EVP, CFO & Treasurer
GrantRestricted Stock Unit · Derivative 75,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-027519 · ownership.xml · derivative · entry 1

Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from March 1, 2024 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from March 1, 2024 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:10 UTC
Somer JasonEVP, Gen. Counsel & Secretary
GrantRestricted Stock Unit · Derivative 21,996 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026543 · ownership.xml · derivative · entry 6

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,996

Underlying: Common Stock · 21,996 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F6 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F6 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:10 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Exercise / conversionRestricted Stock Unit · Derivative 4,680 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026543 · ownership.xml · derivative · entry 5

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,359

Underlying: Common Stock · 4,680 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F5 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F5 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:10 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Exercise / conversionRestricted Stock Unit · Derivative 1,894 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026543 · ownership.xml · derivative · entry 4

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,893

Underlying: Common Stock · 1,894 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F4 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F4 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:10 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Exercise / conversionRestricted Stock Unit · Derivative 576 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026543 · ownership.xml · derivative · entry 3

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,459

Underlying: Common Stock · 576 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:10 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Tax withholdingCommon Stock 4,576 $7.03 $32,146.40
Disclosure

SEC source: 0000950170-24-026543 · ownership.xml · nonDerivative · entry 2

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,488

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:10 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Exercise / conversionCommon Stock 7,150 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026543 · ownership.xml · nonDerivative · entry 1

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,064

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:09 UTC
Smith Kevin Raymond MerrillDirector · CEO and President
GrantRestricted Stock Unit · Derivative 85,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026542 · ownership.xml · derivative · entry 1

Smith Kevin Raymond Merrill · CIK 0001802639 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:08 UTC
Glezer StanislavEVP, R&D & Chief Med. Officer
GrantRestricted Stock Unit · Derivative 43,993 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026541 · ownership.xml · derivative · entry 6

Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,993

Underlying: Common Stock · 43,993 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F6 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F6 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:08 UTC
Glezer StanislavEVP, R&D & Chief Med. Officer
Exercise / conversionRestricted Stock Unit · Derivative 9,360 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026541 · ownership.xml · derivative · entry 5

Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,719

Underlying: Common Stock · 9,360 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F5 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F5 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:08 UTC
Glezer StanislavEVP, R&D & Chief Med. Officer
Exercise / conversionRestricted Stock Unit · Derivative 3,786 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026541 · ownership.xml · derivative · entry 4

Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,787

Underlying: Common Stock · 3,786 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F4 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F4 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:08 UTC
Glezer StanislavEVP, R&D & Chief Med. Officer
Exercise / conversionRestricted Stock Unit · Derivative 768 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026541 · ownership.xml · derivative · entry 3

Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,612

Underlying: Common Stock · 768 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:08 UTC
Glezer StanislavEVP, R&D & Chief Med. Officer
Tax withholdingCommon Stock 7,623 $7.03 $53,551.58
Disclosure

SEC source: 0000950170-24-026541 · ownership.xml · nonDerivative · entry 2

Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,106

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:08 UTC
Glezer StanislavEVP, R&D & Chief Med. Officer
Exercise / conversionCommon Stock 13,914 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026541 · ownership.xml · nonDerivative · entry 1

Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,729

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2023 Filed Dec 4, 2023 23:30 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Exercise / conversionRestricted Stock Unit · Derivative 576 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-057305 · doc4.xml · derivative · entry 3

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,035

Underlying: Common Stock · 576 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

Read SEC document
December 01, 2023 Filed Dec 4, 2023 23:30 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Tax withholdingCommon Stock 286 $5.72 $1,635.92
Disclosure

SEC source: 0001209191-23-057305 · doc4.xml · nonDerivative · entry 2

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,914

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2023.

Read SEC document
December 01, 2023 Filed Dec 4, 2023 23:30 UTC
Somer JasonEVP, Gen. Counsel & Secretary
Exercise / conversionCommon Stock 576 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-057305 · doc4.xml · nonDerivative · entry 1

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2023 Filed Dec 4, 2023 23:29 UTC
Glezer StanislavEVP, Chief Technology Officer
Exercise / conversionRestricted Stock Unit · Derivative 3,786 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-057302 · doc4.xml · derivative · entry 4

Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,787

Underlying: Common Stock · 3,786 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F4 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.

F4 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.